Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Payables (2020 - 2025)

P3 Health Partners (PIII) has disclosed Payables for 5 consecutive years, with $14.8 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Payables rose 1687.0% year-over-year to $14.8 million, compared with a TTM value of $14.8 million through Jun 2025, up 1687.0%, and an annual FY2024 reading of $8.4 million, changed N/A over the prior year.
  • Payables was $14.8 million for Q2 2025 at P3 Health Partners, up from $796000.0 in the prior quarter.
  • Across five years, Payables topped out at $24.1 million in Q1 2022 and bottomed at $208000.0 in Q3 2024.
  • Average Payables over 4 years is $11.7 million, with a median of $11.6 million recorded in 2022.
  • The sharpest move saw Payables crashed 98.21% in 2024, then skyrocketed 1687.0% in 2025.
  • Year by year, Payables stood at $11.5 million in 2022, then increased by 0.76% to $11.6 million in 2023, then fell by 27.41% to $8.4 million in 2024, then skyrocketed by 75.91% to $14.8 million in 2025.
  • Business Quant data shows Payables for PIII at $14.8 million in Q2 2025, $796000.0 in Q1 2025, and $8.4 million in Q4 2024.